참고문헌
- Templin C, Ghadri JR, Diekmann J, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 2015;373:929-38.
- Medina de Chazal H, Del Buono MG, Keyser-Marcus L, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol 2018;72:1955-71.
- Hurst RT, Prasad A, Askew JW 3rd, Sengupta PP, Tajik AJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging 2010;3:641-9.
- Kurowski V, Kaiser A, von Hof K, et al. Apical and midventricular transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): frequency, mechanisms, and prognosis. Chest 2007;132:809-16.
- Haghi D, Papavassiliu T, Fluchter S, et al. Variant form of the acute apical ballooning syndrome (Takotsubo cardiomyopathy): observations on a novel entity. Heart 2006;92:392-4.
- Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008;155:408-17.
- Ghadri JR, Cammann VL, Jurisic S, et al.; InterTAK co-investigators. A novel clinical score (InterTAK Diagnostic Score) to differentiate Takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail 2017;19:1036-42.
- Ghadri JR, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39:2032-46.
- Redfors B, Jha S, Thorleifsson S, et al. Short- and long-term clinical outcomes for patients with Takotsubo syndrome and patients with myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry. J Am Heart Assoc 2021;10:e017290.
- Ghadri JR, Kato K, Cammann VL, et al. Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 2018;72:874-82.
- Ahmed KA, Madhavan M, Prasad A. Brain natriuretic peptide in apical ballooning syndrome (Takotsubo/stress cardiomyopathy): comparison with acute myocardial infarction. Coron Artery Dis 2012;23:259-64.
- Paur H, Wright PT, Sikkel MB, et al. High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 2012;126:697-706.
- Randhawa MS, Dhillon AS, Taylor HC, Sun Z, Desai MY. Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. J Card Fail 2014;20:377.e25-31.
- Madhavan M, Borlaug BA, Lerman A, Rihal CS, Prasad A. Stress hormone and circulating biomarker profile of apical ballooning syndrome (Takotsubo cardiomyopathy): insights into the clinical significance of B-type natriuretic peptide and troponin levels. Heart 2009;95:1436-41.
- Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo syndrome. Circulation 2017;135:2426-41.
- Scally C, Abbas H, Ahearn T, et al. Myocardial and systemic inflammation in acute stress-induced (Takotsubo) cardiomyopathy. Circulation 2019;139:1581-92.
- Ancona F, Bertoldi LF, Ruggieri F, et al. Takotsubo cardiomyopathy and neurogenic stunned myocardium: similar albeit different. Eur Heart J 2016;37:2830-2.
- Godsman N, Kohlhaas M, Nickel A, et al. Metabolic alterations in a rat model of Takotsubo syndrome. Cardiovasc Res 2022;118:1932-46.
- Morel O, Sauer F, Imperiale A, et al. Importance of inflammation and neurohumoral activation in Takotsubo cardiomyopathy. J Card Fail 2009;15:206-13.
- Lachmet-Thebaud L, Marchandot B, Matsushita K, et al. Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients. ESC Heart Fail 2021;8:259-69.
- Wilson HM, Cheyne L, Brown PA, et al. Characterization of the myocardial inflammatory response in acute stress-induced (Takotsubo) cardiomyopathy. JACC Basic Transl Sci 2018;3:766-78.
- Nef HM, Mollmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007;28:2456-64.
- Kawai S, Suzuki H, Yamaguchi H, et al. Ampulla cardiomyopathy ('Takotusbo' cardiomyopathy)--reversible left ventricular dysfunction: with ST segment elevation. Jpn Circ J 2000;64:156-9.
- Mirijello A, D'Errico MM, Curci S, et al. Takotsubo syndrome and inflammatory bowel diseases: does a link exist? Dig Dis 2020;38:204-10.
- Serzan M, Rapisuwon S, Krishnan J, Chang IC, Barac A. Takotsubo cardiomyopathy associated with checkpoint inhibitor therapy: endomyocardial biopsy provides pathological insights to dual diseases. JACC CardioOncol 2021;3:330-4.
- Ahtarovski KA, Iversen KK, Christensen TE, et al. Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2014;15:855-62.
- Alashi A, Isaza N, Faulx J, et al. Characteristics and outcomes of patients with Takotsubo syndrome: incremental prognostic value of baseline left ventricular systolic function. J Am Heart Assoc 2020;9:e016537.
- Citro R, Radano I, Parodi G, et al. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction. Eur J Heart Fail 2019;21:781-9.
- Murugiah K, Wang Y, Desai NR, et al. Trends in short- and long-term outcomes for Takotsubo cardiomyopathy among medicare fee-for-service beneficiaries, 2007 to 2012. JACC Heart Fail 2016;4:197-205.
- Butt JH, Bang LE, Rorth R, et al. Long-term risk of death and hospitalization in patients with heart failure and Takotsubo syndrome: insights from a nationwide cohort. J Card Fail 2022;28:1534-44.